We are excited to have recruited our first patient to the ADAPT-Sepsis study!🎉An important study aiming to determine whether the duration of antibiotic treatment given to patients with sepsis can be safely reduced with daily monitoring of biomarkers CRP and PCT #Sepsis #Research